The SMA test can be performed during pregnancy if there is a clinical indication or suspicion of autoimmune liver diseases. However, the decision to perform the test during pregnancy should be carefully considered, and healthcare providers will take into account the potential impact on the pregnancy and the health of both the mother and the fetus. The benefits and risks of the test in pregnancy will be assessed by the healthcare team.